反応式
[Cl:1][C:2]1[CH:9]=[C:8]([Cl:10])[CH:7]=[CH:6][C:3]=1[CH:4]=O.[CH3:11][C:12](=O)[CH:13]=[CH2:14].[N:16]1([S:22]([C:25]2[CH:30]=[CH:29][C:28]([NH2:31])=[CH:27][CH:26]=2)(=[O:24])=[O:23])[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17]1>>[Cl:1][C:2]1[CH:9]=[C:8]([Cl:10])[CH:7]=[CH:6][C:3]=1[C:4]1[N:31]([C:28]2[CH:29]=[CH:30][C:25]([S:22]([N:16]3[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17]3)(=[O:24])=[O:23])=[CH:26][CH:27]=2)[C:12]([CH3:11])=[CH:13][CH:14]=1参加物
4
実験手順
2,4-Dichlorobenzaldehyde and but-3-en-2-one were treated according to the procedure outlined in General Procedure C followed by subjecting the resulting product to conditions outlined in General Procedure D along with p-piperidinylsulfonyl phenylamine to obtain the titled compound. 1H NMR (CDCl3) δ ppm 1.50 (6H), 2.10 (3H), 2.80 (4H), 6.08 (1H), 6.35 (1H), 7.33-7.90 (7H); MS (ESI) m/z 449/451 (M+H).
出典と根拠
- ORDレコード
- ord-36737fdcfcb24e1d99dd19a0931e567f
- 出典データセット
- uspto-grants-2010_06
- 特許番号
- US07741364B2
関連ノート
読み込み中…